Advances in Development and Application of Influenza Vaccines.


Journal

Frontiers in immunology
ISSN: 1664-3224
Titre abrégé: Front Immunol
Pays: Switzerland
ID NLM: 101560960

Informations de publication

Date de publication:
2021
Historique:
received: 19 05 2021
accepted: 24 06 2021
entrez: 30 7 2021
pubmed: 31 7 2021
medline: 21 12 2021
Statut: epublish

Résumé

Influenza A virus is one of the most important zoonotic pathogens that can cause severe symptoms and has the potential to cause high number of deaths and great economic loss. Vaccination is still the best option to prevent influenza virus infection. Different types of influenza vaccines, including live attenuated virus vaccines, inactivated whole virus vaccines, virosome vaccines, split-virion vaccines and subunit vaccines have been developed. However, they have several limitations, such as the relatively high manufacturing cost and long production time, moderate efficacy of some of the vaccines in certain populations, and lack of cross-reactivity. These are some of the problems that need to be solved. Here, we summarized recent advances in the development and application of different types of influenza vaccines, including the recent development of viral vectored influenza vaccines. We also described the construction of other vaccines that are based on recombinant influenza viruses as viral vectors. Information provided in this review article might lead to the development of safe and highly effective novel influenza vaccines.

Identifiants

pubmed: 34326849
doi: 10.3389/fimmu.2021.711997
pmc: PMC8313855
doi:

Substances chimiques

Influenza Vaccines 0
Vaccines, Attenuated 0
Vaccines, Inactivated 0
Vaccines, Subunit 0
Vaccines, Synthetic 0
Vaccines, Virosome 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

711997

Informations de copyright

Copyright © 2021 Chen, Wang, Zhang and Ly.

Déclaration de conflit d'intérêts

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Références

NPJ Vaccines. 2017 Dec 4;2:33
pubmed: 29263888
Sci China Life Sci. 2018 Nov;61(11):1442-1444
pubmed: 30361895
Pathogens. 2020 Aug 18;9(8):
pubmed: 32824873
Microbiol Immunol. 2020 Apr;64(4):313-325
pubmed: 31957054
Nature. 2009 Jun 25;459(7250):1122-5
pubmed: 19516283
J Med Virol. 2012 Sep;84(9):1408-14
pubmed: 22825819
Nature. 2008 Jan 31;451(7178):591-5
pubmed: 18235503
J Gen Virol. 2013 Jun;94(Pt 6):1175-1188
pubmed: 23364194
J Virol. 2015 Dec 16;90(5):2551-60
pubmed: 26676795
Viruses. 2020 Feb 19;12(2):
pubmed: 32093076
Am J Public Health. 2020 May;110(5):669-676
pubmed: 32267748
J Virol. 2006 Dec;80(23):11756-66
pubmed: 16971435
Pediatrics. 1997 Jul;100(1):E9
pubmed: 9200383
Rev Med Virol. 2019 Nov;29(6):e2074
pubmed: 31334909
N Engl J Med. 2017 Jun 22;376(25):2427-2436
pubmed: 28636855
PLoS Pathog. 2015 Nov 20;11(11):e1005276
pubmed: 26587982
Hum Vaccin Immunother. 2016 Dec;12(12):3072-3078
pubmed: 27565435
Proc Natl Acad Sci U S A. 2007 Jun 5;104(23):9788-93
pubmed: 17535926
J Gen Virol. 2003 Apr;84(Pt 4):781-788
pubmed: 12655078
Viruses. 2019 Mar 26;11(3):
pubmed: 30917500
Clin Exp Vaccine Res. 2017 Jul;6(2):72-82
pubmed: 28775971
Vet Microbiol. 2019 Jan;228:173-180
pubmed: 30593364
Expert Rev Vaccines. 2009 Jun;8(6):761-77
pubmed: 19485756
Viruses. 2020 Mar 26;12(4):
pubmed: 32224899
J Infect Dis. 2016 Jan 1;213(1):31-8
pubmed: 26142433
Expert Rev Vaccines. 2019 Apr;18(4):379-392
pubmed: 30777467
Int J Mol Sci. 2020 Jul 08;21(14):
pubmed: 32650405
Nat Med. 2021 Jan;27(1):106-114
pubmed: 33288923
Biotechnol J. 2015 May;10(5):702-14
pubmed: 25800821
mBio. 2019 Sep 17;10(5):
pubmed: 31530680
Emerg Infect Dis. 2012 Aug;18(8):1256-62
pubmed: 22839997
N Engl J Med. 2006 May 25;354(21):2235-49
pubmed: 16723615
Lancet. 1975 Nov 8;2(7941):899-901
pubmed: 53375
Nature. 2009 Jun 18;459(7249):931-9
pubmed: 19525932
Avian Dis. 2018 Dec 17;63(1):75-83
pubmed: 31251522
Hum Vaccin Immunother. 2018 Mar 4;14(3):657-670
pubmed: 29297746
J Virol. 1989 Mar;63(3):1239-46
pubmed: 2915381
Curr Gene Ther. 2011 Aug;11(4):307-20
pubmed: 21453277
J Am Chem Soc. 2011 Jun 29;133(25):9903-11
pubmed: 21534619
Methods Mol Biol. 2016;1404:3-35
pubmed: 27076287
Front Immunol. 2021 Jan 29;11:607333
pubmed: 33633727
Br Vet J. 1978 Jul-Aug;134(4):315-21
pubmed: 209848
Nat Med. 2010 Mar;16(3):339-45
pubmed: 20139992
Drugs. 2013 Aug;73(12):1357-66
pubmed: 23928902
Virol J. 2020 Aug 5;17(1):121
pubmed: 32758272
Vaccine. 2013 Nov 4;31(46):5398-404
pubmed: 24055355
Science. 2008 Apr 18;320(5874):340-6
pubmed: 18420927
Ther Adv Vaccines. 2015 Jul;3(4):97-108
pubmed: 26478817
Viruses. 2012 Sep;4(9):1438-76
pubmed: 23170167
Lancet Infect Dis. 2020 Jan;20(1):80-91
pubmed: 31630990
Hum Vaccin Immunother. 2018;14(12):2971-2978
pubmed: 30183490
AAPS PharmSciTech. 2019 Oct 7;20(8):315
pubmed: 31591662
Microbes Infect. 2011 Apr;13(4):303-11
pubmed: 21238601
Avian Pathol. 2001 Oct;30(5):439-55
pubmed: 19184932
Virology. 2019 Mar;529:7-15
pubmed: 30641481
PLoS One. 2017 Oct 12;12(10):e0186244
pubmed: 29023601
Expert Rev Vaccines. 2019 Jun;18(6):615-628
pubmed: 31116070
Annu Rev Public Health. 2021 Apr 1;42:43-57
pubmed: 33348997
Vaccine. 1997 Oct;15(15):1675-9
pubmed: 9364699
Immunology. 2006 Sep;119(1):1-7
pubmed: 16925526
J Infect Dis. 2013 Apr;207(7):1037-46
pubmed: 23372182
Virology. 2019 Sep;535:179-188
pubmed: 31310875
Science. 2004 Jul 16;305(5682):371-6
pubmed: 15218094
Proc Natl Acad Sci U S A. 2020 Jul 21;117(29):17204-17210
pubmed: 32601207
Methods Mol Biol. 2014;1161:37-50
pubmed: 24899418
Viral Immunol. 2017 Jul/Aug;30(6):451-462
pubmed: 28650274
J Virol. 2011 Aug;85(15):7928-32
pubmed: 21613399
Vaccine. 2019 Aug 14;37(35):4956-4962
pubmed: 31320218
Clin Microbiol Infect. 2017 Apr;23(4):222-228
pubmed: 28216325
Vaccine. 2015 Feb 25;33(9):1197-205
pubmed: 25613723
Curr Top Microbiol Immunol. 1992;176:119-30
pubmed: 1600749
PLoS One. 2018 Jan 29;13(1):e0191574
pubmed: 29377916
Viral Immunol. 2018 Jan/Feb;31(1):23-33
pubmed: 28714781
Mol Ther Methods Clin Dev. 2018 Jul 17;10:210-222
pubmed: 30101154
Virus Res. 2017 Apr 15;234:103-117
pubmed: 28115197
J Virol. 2020 May 18;94(11):
pubmed: 32161172
Viral Immunol. 2016 May;29(4):198-211
pubmed: 26900835
Virology. 2018 Mar;516:76-85
pubmed: 29331866
Vaccine. 2009 Jul 16;27(33):4381-7
pubmed: 19450630
Cold Spring Harb Perspect Med. 2020 Mar 23;:
pubmed: 32205415
MMWR Morb Mortal Wkly Rep. 2008 Jul 25;57(29):799-801
pubmed: 18650788
Virology. 2017 Mar;503:31-36
pubmed: 28110247
Int J Mol Sci. 2016 Dec 22;18(1):
pubmed: 28025504
New Microbiol. 2013 Jan;36(1):1-22
pubmed: 23435812
EMBO J. 1985 Nov;4(11):3021-4
pubmed: 4065098
Pharm Res. 2015 Apr;32(4):1505-15
pubmed: 25344321
J Gen Virol. 2014 Jan;95(Pt 1):1-15
pubmed: 24068704
Nat Commun. 2015 Mar 25;6:6600
pubmed: 25807527
Viruses. 2021 Mar 24;13(4):
pubmed: 33805245
Virus Res. 2016 May 2;216:26-40
pubmed: 26220478
Methods Mol Biol. 2017;1581:169-179
pubmed: 28374249
Arch Virol. 2016 Aug;161(8):2087-94
pubmed: 27255748
Influenza Other Respir Viruses. 2013 May;7(3):249-56
pubmed: 22712782
Expert Rev Vaccines. 2013 Jul;12(7):779-91
pubmed: 23885823
Immunol Rev. 2018 Jul;284(1):91-105
pubmed: 29944766
Vaccines (Basel). 2020 May 14;8(2):
pubmed: 32422944
Mol Ther. 2017 Nov 1;25(11):2533-2545
pubmed: 28803862
J Immunol. 2020 Jan 15;204(2):375-385
pubmed: 31811019
Proc Natl Acad Sci U S A. 2009 Mar 3;106(9):3473-8
pubmed: 19208813
Curr Opin Virol. 2013 Oct;3(5):521-30
pubmed: 23978327
Am J Epidemiol. 1985 Jun;121(6):811-22
pubmed: 4014174
Lancet Infect Dis. 2017 Dec;17(12):1221-1222
pubmed: 28958679
Bioengineered. 2012 Sep-Oct;3(5):271-4
pubmed: 22705893
Adv Exp Med Biol. 2014;841:15-44
pubmed: 25261203
Viruses. 2019 Feb 22;11(2):
pubmed: 30813325
J Pediatric Infect Dis Soc. 2013 Dec;2(4):368-78
pubmed: 26619499
Vaccine. 2020 Feb 18;38(8):1953-1961
pubmed: 31959425
Cell Rep Med. 2021 Mar 03;2(3):100209
pubmed: 33763654
Vet Microbiol. 2016 Aug 15;191:35-43
pubmed: 27374905
Vet Microbiol. 2010 Jan 27;140(3-4):213-20
pubmed: 19748747
Med Lett Drugs Ther. 2020 Sep 21;62(1607):145-150
pubmed: 32960868
Vet Microbiol. 2017 Jul;206:144-151
pubmed: 27916319
Virus Res. 2011 Jan;155(1):163-7
pubmed: 20875469
Front Microbiol. 2017 Apr 20;8:693
pubmed: 28473820
Pediatrics. 2019 Feb;143(2):
pubmed: 30617239
Curr Opin Immunol. 2018 Aug;53:102-110
pubmed: 29734023
Nat Med. 2010 Dec;16(12):1389-91
pubmed: 21135852
Antiviral Res. 2017 Nov;147:29-36
pubmed: 28941982
Virus Res. 2014 Jun 24;185:53-63
pubmed: 24675275
J Virol. 2010 Feb;84(3):1489-503
pubmed: 19923177
Biotechnol Adv. 2009 May-Jun;27(3):297-306
pubmed: 19500547
J Clin Virol. 2019 Oct;119:44-52
pubmed: 31491709
Viruses. 2019 Apr 16;11(4):
pubmed: 31014029
Front Microbiol. 2016 May 06;7:635
pubmed: 27199961
J Am Med Assoc. 1958 Mar 8;166(10):1140-8
pubmed: 13513331
J Infect Dis. 2020 Apr 7;221(9):1528-1537
pubmed: 32255493
J Virol. 2007 Jun;81(12):6379-88
pubmed: 17428868
PLoS Pathog. 2013;9(10):e1003657
pubmed: 24130481
Infect Immun. 1974 May;9(5):821-3
pubmed: 4856825
PLoS One. 2011 Mar 28;6(3):e18314
pubmed: 21464940
Expert Rev Vaccines. 2009 Apr;8(4):455-67
pubmed: 19348561
Influenza Other Respir Viruses. 2013 Nov;7(6):1168-74
pubmed: 23981250
J Virol. 2001 Dec;75(23):11868-73
pubmed: 11689668
Vaccines (Basel). 2020 Oct 01;8(4):
pubmed: 33019589
Methods Mol Biol. 2020;2123:37-59
pubmed: 32170679
Vaccine. 2005 Jul 8;23 Suppl 1:S26-38
pubmed: 16026906
PLoS One. 2020 Feb 26;15(2):e0229279
pubmed: 32101582
Tierarztl Prax Ausg G Grosstiere Nutztiere. 2014;42(6):351-9
pubmed: 25405955
Vaccines (Basel). 2021 Mar 13;9(3):
pubmed: 33805749
Clin Infect Dis. 2001 Aug 1;33(3):370-4
pubmed: 11438904
Bull World Health Organ. 1969;41(3):345-8
pubmed: 5309437
Clin Infect Dis. 2018 Feb 10;66(5):665-672
pubmed: 29029064
Hum Vaccin Immunother. 2020 Nov 1;16(11):2719-2726
pubmed: 32186950
Viruses. 2018 Aug 28;10(9):
pubmed: 30154345
Vaccines (Basel). 2020 Apr 24;8(2):
pubmed: 32344618
Transbound Emerg Dis. 2018 Dec;65(6):1733-1739
pubmed: 29992783
J Immunol. 2008 Aug 1;181(3):2134-44
pubmed: 18641352
Avian Dis. 2013 Dec;57(4):750-5
pubmed: 24597117
J Virol. 2005 Nov;79(21):13275-84
pubmed: 16227250
PLoS Pathog. 2021 Apr 27;17(4):e1009561
pubmed: 33905456
Lancet. 1994 Jul 16;344(8916):160-3
pubmed: 7912766
PLoS One. 2016 Mar 01;11(3):e0150678
pubmed: 26930068
J Vet Med Sci. 2015 Jan;77(1):109-12
pubmed: 25298239
Viruses. 2016 Jul 04;8(7):
pubmed: 27384578
Eur J Pharm Biopharm. 2015 Aug;94:251-63
pubmed: 26047796
Clin Infect Dis. 2019 Nov 13;69(11):1845-1853
pubmed: 30715278
Viruses. 2014 Jun 23;6(6):2465-94
pubmed: 24960271
Vaccine. 2008 Aug 18;26(35):4579-84
pubmed: 18602729
Annu Rev Virol. 2017 Sep 29;4(1):141-158
pubmed: 28645238
Hum Vaccin Immunother. 2014;10(3):557-65
pubmed: 24301228
Lancet. 2000 Mar 4;355(9206):827-35
pubmed: 10711940
Viruses. 2018 May 31;10(6):
pubmed: 29857561
Semin Pediatr Neurol. 2012 Sep;19(3):89-95
pubmed: 22889536
J Pediatr Hematol Oncol. 2008 Oct;30(10):781-4
pubmed: 19011481
Avian Dis. 2016 Mar;60(1):22-32
pubmed: 26953940
J Virol. 2007 Apr;81(7):3170-80
pubmed: 17229689
Vaccines (Basel). 2020 Nov 13;8(4):
pubmed: 33202961
Proc Jpn Acad Ser B Phys Biol Sci. 2012;88(6):226-49
pubmed: 22728439
Transbound Emerg Dis. 2019 Nov;66(6):2605-2610
pubmed: 31402584
Elife. 2020 Oct 13;9:
pubmed: 33048046
Curr Top Microbiol Immunol. 2014;385:359-75
pubmed: 24990620
Expert Rev Vaccines. 2016;15(2):201-14
pubmed: 26641539
Lancet Respir Med. 2019 Aug;7(8):665-676
pubmed: 31235405
J Infect Dev Ctries. 2019 Jun 30;13(6):536-544
pubmed: 32058989
Biotechnol J. 2018 Apr;13(4):e1700645
pubmed: 29278302
Influenza Other Respir Viruses. 2020 Mar;14(2):162-172
pubmed: 31872547
Cell Host Microbe. 2018 Oct 10;24(4):558-568.e7
pubmed: 30269969
Antiviral Res. 2020 Oct;182:104864
pubmed: 32585323
Curr Top Microbiol Immunol. 2016;392:231-76
pubmed: 26472215
Int J Parasitol Parasites Wildl. 2021 Jan 27;14:130-136
pubmed: 33659179
J Leukoc Biol. 2020 Nov;108(5):1655-1663
pubmed: 32386456
J Virol. 2007 Nov;81(21):11560-8
pubmed: 17715243
Trends Ecol Evol. 1998 Sep 1;13(9):361-6
pubmed: 21238344
Front Immunol. 2018 Jul 20;9:1581
pubmed: 30079062
Curr Med Chem. 2018;25(38):5115-5127
pubmed: 28933281
J Proteomics. 2019 Apr 15;197:34-41
pubmed: 30790688
Viral Immunol. 2018 Mar;31(2):174-183
pubmed: 29373086
Hum Vaccin Immunother. 2018 Jun 3;14(6):1311-1322
pubmed: 29485353
Virology. 2012 Oct 25;432(2):327-35
pubmed: 22726244
Vaccine. 2012 Feb 27;30(10):1759-66
pubmed: 22265860
PLoS One. 2010 Jun 21;5(6):e11158
pubmed: 20574518
Front Med. 2018 Feb;12(1):34-47
pubmed: 29352371
ERJ Open Res. 2018 Apr 09;4(2):
pubmed: 29637079
Emerg Infect Dis. 2017 Sep;23(9):1548-1550
pubmed: 28820372
Hum Vaccin Immunother. 2020 Jul 2;16(7):1691-1698
pubmed: 32347785
Viruses. 2020 Sep 17;12(9):
pubmed: 32957468
Sci Rep. 2017 Nov 2;7(1):14912
pubmed: 29097763
Hum Vaccin Immunother. 2018 Mar 4;14(3):678-683
pubmed: 29337643
Nucleic Acids Res. 2001 Jul 1;29(13):2691-8
pubmed: 11433013
J Virol. 2019 Oct 15;93(21):
pubmed: 31375596
Vaccine. 2011 Oct 26;29(46):8257-66
pubmed: 21907750
Matern Child Health J. 2020 Feb;24(2):229-240
pubmed: 31865602
Nat Commun. 2020 Nov 20;11(1):5909
pubmed: 33219213
J Virol. 2015 Jul;89(14):7401-8
pubmed: 25926639
Immunol Invest. 2020 Oct;49(7):781-793
pubmed: 31774021
J Infect Dis. 2019 Apr 8;219(Suppl_1):S62-S67
pubmed: 30715353
J Virol. 1993 Jun;67(6):2972-80
pubmed: 8497041
J Virol. 2014 Oct;88(20):12123-32
pubmed: 25122778
Adv Virus Res. 2006;68:193-253
pubmed: 16997013
Science. 2005 Oct 7;310(5745):77-80
pubmed: 16210530
Virology. 1994 Aug 1;202(2):586-605
pubmed: 8030224
Bull Hist Med. 2002 Spring;76(1):105-15
pubmed: 11875246
PLoS One. 2012;7(3):e33428
pubmed: 22432020
Sci Rep. 2018 Nov 15;8(1):16854
pubmed: 30443041
Nucleic Acids Res. 2011 Jan;39(1):e4
pubmed: 20959296

Auteurs

Jidang Chen (J)

School of Life Science and Engineering, Foshan University, Foshan, China.

Jiehuang Wang (J)

School of Life Science and Engineering, Foshan University, Foshan, China.

Jipei Zhang (J)

School of Life Science and Engineering, Foshan University, Foshan, China.

Hinh Ly (H)

Department of Veterinary & Biomedical Sciences, University of Minnesota, Twin Cities, MN, United States.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH